Clinical Trial Update: Nimotuzumab Combined With VMAT in Elderly Patients With Nasopharyngeal Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating nimotuzumab in combination with VMAT for elderly patients with nasopharyngeal carcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasopharyngeal Carcinoma

Drugs mentioned

• Nimotuzumab (nimotuzumab)

Snippet

Sponsor: Chinese Academy of Medical Sciences | Conditions: Nasopharyngeal Carcinoma | Phase 2 | Status: UNKNOWN